Bradley Saenger
Vermögen: 21 562 $ am 31.07.2026
Vermögen: 21 562 $ am 31.07.2026
Bradley Saenger currently works at Tonix Pharma Holdings Ltd., as Director from 2015 and Tonix Pharmaceuticals Holding Corp., as Chief Financial Officer & Treasurer from 2016.
Mr. Saenger also formerly worked at Vertex Pharmaceuticals, Inc., as Associate Director-Accounting from 2011 to 2012 and Alere, Inc., as Manager-Corporate Accounting & Consolidations from 2007 to 2011.
Mr. Saenger received his undergraduate degree from the University of South Africa.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2026 | 2’154 ( 0.02% ) | 21 562 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Finanzdirektor/CFO | 01.02.2016 |
Tonix Pharma Holdings Ltd. | Direktor/Vorstandsmitglied | 01.11.2015 |
| Unternehmen | Position | Ende |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | 01.12.2012 |
| ALERE INC | Finanzdirektor/CFO | 01.09.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Alere, Inc.
Alere, Inc. Medical SpecialtiesHealth Technology Manufactures point-of-care diagnostic tests | Health Technology |
University of South Africa
University of South Africa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
Tonix Pharma Holdings Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen